- Social media lights up with reports of Victorian meteor flash MSN
- Watch: Meteor burns across Australian night sky BBC
- What was that loud bang? Australian Broadcasting Corporation
- Meteor Shower Magic Over Victoria Tonight: What You Need to Know Vocal
- What we know about the meteor that dazzled Victoria and lit up parts of Melbourne The Age
Author: admin
-
Social media lights up with reports of Victorian meteor flash – MSN
-
Pakistan: Bomb blast derails six train bogies with 350 passengers onboard
No loss of life was reported after a bomb blast on a railway track in Balochistan’s Mastung district derailed six bogies of the Jaffar Express, an official said on Sunday, Dawn reported.
Muhammad Kashif, public relations officer of the Pakistan Railways’ Quetta division, told Dawn, “A bomb attached to the railway track exploded loudly, derailing six bogies of the train. Fortunately, there was no loss of life.”
The incident occurred near the Spezand station in Mastung’s Dasht tehsil, when the train was heading from Quetta to Peshawar City station with 350 passengers on board, the news outlet added.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
“Security forces and rescue teams rushed to the site as soon as they were alerted about the incident, and began a search operation after cordoning off the area,” Kashif said.
He further noted, “Four bogies of the Jaffar Express had been placed back on the track, while efforts were underway to restore the other two.”
A relief train of the Pakistan Railways brought the 350 passengers back to Quetta, while bogies stuck on the track will be returned to the city as well, Kashif said in a later statement, adding that all tickets will be refunded.
In a separate statement, Kashif said the services of the Jaffar Express and Bolan Mail were suspended till August 14. The Bolan Mail will resume its operations on August 16 (Saturday), when it will depart from Karachi “in its proper turn” and will arrive in Quetta the next day, he added.
This incident comes just three days after the Quetta-bound Jaffar Express narrowly escaped disaster in Balochistan’s Sibi, where a bomb planted near the track exploded just after the passenger train passed, Dawn reported.
On July 24, a powerful explosion ripped through the Quetta-Sibi rail section, damaging a bogie of the Bolan Mail. A July 28 derailment of the Jaffar Express train in Sindh’s Sukkur was initially attributed to an explosion, even by government-run media, but the Ministry of Railways later said a technical fault was the cause.
In June, a powerful explosion of a remotely controlled explosive device fitted to rail tracks caused four bogies of the Jaffar Express to derail in Jacobabad. No one was hurt in the incident.
In April, the 3UP train heading from Karachi to Quetta was stopped at Jacobabad railway station due to security reasons.
Train services between Quetta and the rest of the country were restored on March 27, after they were suspended due to the unprecedented hijacking of the Peshawar-bound Jaffar Express earlier that month. The train, travelling from Quetta to Peshawar and carrying 440 passengers, was hijacked near Balochistan’s Sibi area on March 11, resulting in the deaths of 21 passengers and four security personnel.
“All 33 terrorists” were neutralised during the two-day clearance operation, the military said.
Continue Reading
-
Dexamethasone for prevention of AMS, HACE, and HAPE and for limiting impairment of performance after rapid ascent to high altitude: a narrative review | Military Medical Research
Gatterer H, Villafuerte FC, Ulrich S, Bhandari SS, Keyes LE, Burtscher M. Altitude illnesses Nat Rev Dis Primers. 2024;10(1):43.
Google Scholar
Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345(2):107–14.
Google Scholar
Burtscher M, Hefti U, Hefti JP. High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention. Sports Med Health Sci. 2021;3(2):59–69.
Google Scholar
Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325(18):1284–9.
Google Scholar
Swenson ER, Bärtsch P. High-altitude pulmonary edema. Compr Physiol. 2012;2(4):2753–73.
Google Scholar
Mairer K, Wille M, Burtscher M. The prevalence of and risk factors for acute mountain sickness in the Eastern and Western Alps. High Alt Med Biol. 2010;11(4):343–8.
Google Scholar
Maggiorini M, Buhler B, Walter M, Oelz O. Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 1990;301(6756):853–5.
Google Scholar
Richalet JP, Larmignat P, Poitrine E, Letournel M, Canouï-Poitrine F. Physiological risk factors for severe high-altitude illness: a prospective cohort study. Am J Respir Crit Care Med. 2012;185(2):192–8.
Google Scholar
Burtscher J, Swenson ER, Hackett P, Millet GP, Burtscher M. Flying to high-altitude destinations: is the risk of acute mountain sickness greater?. J Travel Med. 2023;30(4):taad011.
Google Scholar
Beidleman BA, Tighiouart H, Schmid CH, Fulco CS, Muza SR. Predictive models of acute mountain sickness after rapid ascent to various altitudes. Med Sci Sports Exerc. 2013;45(4):792–800.
Google Scholar
Beidleman BA, Fulco CS, Cymerman A, Staab JE, Buller MJ, Muza SR. New metric of hypoxic dose predicts altitude acclimatization status following various ascent profiles. Physiol Rep. 2019;7(20): e14263.
Google Scholar
O’Hara R, Serres J, Dodson W, Bruce W, Ordway J, Powell E, et al. The use of dexamethasone in support of high-altitude ground operations and physical performance: review of the literature. J Spec Oper Med. 2014;14(4):53–8.
Google Scholar
Seiler T, Nakas CT, Brill AK, Hefti U, Hilty MP, Perret-Hoigné E, et al. Do cardiopulmonary exercise tests predict summit success and acute mountain sickness? A prospective observational field study at extreme altitude. Br J Sports Med. 2023;57(14):906–13.
Google Scholar
McMorris T, Hale BJ, Barwood M, Costello J, Corbett J. Effect of acute hypoxia on cognition: a systematic review and meta-regression analysis. Neurosci Biobehav Rev. 2017;74(Pt A):225–32.
Google Scholar
Sampson JB, Kobrick JL. The environmental symptoms questionnaire: revisions and new filed data. Aviat Space Environ Med. 1980;51(9 Pt 1):872–7.
Google Scholar
Roach RC, Bärtsch P, Hackett PH, Oelz O. The Lake Louise Acute Mountain Sickness Scoring System. In: Sutton JRHC, Coates G, editors. Hypoxia and Molecular Medicine. Burlington: Queen City Press; 1993. p. 272–4.
Roach RC, Hackett PH, Oelz O, Bärtsch P, Luks AM, MacInnis MJ, et al. The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol. 2018;19(1):4–6.
Google Scholar
Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med. 1984;310(11):683–6.
Google Scholar
Rock PB, Johnson TS, Larsen RF, Fulco CS, Trad LA, Cymerman A. Dexamethasone as prophylaxis for acute mountain sickness. Effect of dose level Chest. 1989;95(3):568–73.
Google Scholar
Subudhi AW, Dimmen AC, Julian CG, Wilson MJ, Panerai RB, Roach RC. Effects of acetazolamide and dexamethasone on cerebral hemodynamics in hypoxia. J Appl Physiol (1985). 2011;110(5):1219–25.
Google Scholar
Maggiorini M, Brunner-La Rocca HP, Peth S, Fischler M, Böhm T, Bernheim A, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med. 2006;145(7):497–506.
Google Scholar
Rock PB, Johnson TS, Cymerman A, Burse RL, Falk LJ, Fulco CS. Effect of dexamethasone on symptoms of acute mountain sickness at Pikes Peak, Colorado (4,300 m). Aviat Space Environ Med. 1987;58(7):668–72.
Google Scholar
Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med. 1969;280(4):175–84.
Google Scholar
Hackett PH, Rennie D, Levine HD. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976;2(7996):1149–55.
Google Scholar
Ellsworth AJ, Larson EB, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis. Am J Med. 1987;83(6):1024–30.
Google Scholar
Hackett PH, Roach RC, Wood RA, Foutch RG, Meehan RT, Rennie D, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med. 1988;59(10):950–4.
Google Scholar
Zell SC, Goodman PH. Acetazolamide and dexamethasone in the prevention of acute mountain sickness. West J Med. 1988;148(5):541–5.
Google Scholar
Ellsworth AJ, Meyer EF, Larson EB. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier. West J Med. 1991;154(3):289–93.
Google Scholar
Bernhard WN, Schalick LM, Gittelsohn A. Dexamethasone for prophylaxis against acute mountain sickness during rapid ascent to 5334 m. J Wilderness Med. 1994;5(3):331–8.
Hussain MM, Aslam M, Khan Z. Acute mountain sickness score and hypoxemia. J Pak Med Assoc. 2001;51(5):173–9.
Google Scholar
Zheng CR, Chen GZ, Yu J, Qin J, Song P, Bian SZ, et al. Inhaled budesonide and oral dexamethasone prevent acute mountain sickness. Am J Med. 2014;127(10):1001-9.e2.
Google Scholar
Chanana N, Palmo T, Sharma K, Kumar R, Shah B, Mahajan S, et al. Sexual dimorphism of dexamethasone as a prophylactic treatment in pathologies associated with acute hypobaric hypoxia exposure. Front Pharmacol. 2022;13: 873867.
Google Scholar
Fischler M, Maggiorini M, Dorschner L, Debrunner J, Bernheim A, Kiencke S, et al. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med. 2009;180(4):346–52.
Google Scholar
Siebenmann C, Bloch KE, Lundby C, Nussbamer-Ochsner Y, Schoeb M, Maggiorini M. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m. High Alt Med Biol. 2011;12(2):169–77.
Google Scholar
Spoorenberg SM, Deneer VH, Grutters JC, Pulles AE, Voorn GP, Rijkers GT, et al. Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia. Br J Clin Pharmacol. 2014;78(1):78–83.
Google Scholar
ADVANZPharma. SmPC Dexamethasone 4 mg tablets. https://www.medicinesorguk/emc/product/10720/smpc#gref. 2024. Accessed 10 May 2024.
Lim W, Park C, Shim MK, Lee YH, Lee YM, Lee Y. Glucocorticoids suppress hypoxia-induced COX-2 and hypoxia inducible factor-1α expression through the induction of glucocorticoid-induced leucine zipper. Br J Pharmacol. 2014;171(3):735–45.
Google Scholar
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.
Google Scholar
Huo Y, Rangarajan P, Ling E-A, Dheen ST. Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC Neurosci. 2011;12(1):49.
Google Scholar
Barnes PJ. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 2006;148(3):245–54.
Google Scholar
Johnson TS, Rock PB, Young JB, Fulco CS, Trad LA. Hemodynamic and sympathoadrenal responses to altitude in humans: effect of dexamethasone. Aviat Space Environ Med. 1988;59(3):208–12.
Google Scholar
De Oliveira GS, Castro-Alves LJ, Ahmad S, Kendall MC, McCarthy RJ. Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg. 2013;116(1):58–74.
Google Scholar
Kenna HA, Poon AW, de los Angeles CP, Koran LM. Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci. 2011;65(6):549–60.
Severinghaus JW. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J Appl Physiol (1985). 1995;79(2):375–9.
Google Scholar
Long JB, Holaday JW. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science. 1985;227(4694):1580–3.
Google Scholar
Montgomery AB, Luce JM, Michael P, Mills J. Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes. JAMA. 1989;261(5):734–6.
Google Scholar
Sartori C, Duplain H, Lepori M, Egli M, Maggiorini M, Nicod P, et al. High altitude impairs nasal transepithelial sodium transport in HAPE-prone subjects. Eur Respir J. 2004;23(6):916–20.
Google Scholar
Marquet P, Lac G, Chassain AP, Habrioux G, Galen FX. Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones. J Appl Physiol (1985). 1999;87(1):175–82.
Google Scholar
Jobe JB, Shukitt-Hale B, Banderet LE, Rock PB. Effects of dexamethasone and high terrestrial altitude on cognitive performance and affect. Aviat Space Environ Med. 1991;62(8):727–32.
Google Scholar
Lafleur J, Giron M, Demarco M, Kennedy R, BeLue R, Shields C. Cognitive effects of dexamethasone at high altitude. Wilderness Environ Med. 2003;14(1):20–3.
Google Scholar
Richards RN. Side effects of short-term oral corticosteroids. J Cutan Med Surg. 2008;12(2):77–81.
Google Scholar
Levine BD, Yoshimura K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med. 1989;321(25):1707–13.
Google Scholar
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006;81(10):1361–7.
Google Scholar
Liu B, Yuan M, Yang M, Zhu H, Zhang W. The Effect of high-altitude hypoxia on neuropsychiatric functions. High Alt Med Biol. 2024;25(1):26–41.
Google Scholar
Roach RC, Maes D, Sandoval D, Robergs RA, Icenogle M, Hinghofer-Szalkay H, et al. Exercise exacerbates acute mountain sickness at simulated high altitude. J Appl Physiol (1985). 2000;88(2):581–5.
Google Scholar
Mairer K, Wille M, Bucher T, Burtscher M. Prevalence of acute mountain sickness in the Eastern Alps. High Alt Med Biol. 2009;10(3):239–45.
Google Scholar
Schoene RB, Roach RC, Hackett PH, Harrison G, Mills WJ. High altitude pulmonary edema and exercise at 4400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest. 1985;87:330–3.
Google Scholar
Luks AM, Swenson ER, Bartsch P. Acute high-altitude sickness. Eur Respir Rev. 2017;26(143): 160096.
Google Scholar
Luks AM, Beidleman BA, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness medical society clinical practice guidelines for the prevention, diagnosis, and treatment of acute altitude illness: 2024 update. Wilderness Environ Med. 2024;35(1_suppl):2s–19s.
Google Scholar
Continue Reading
-
Porsche Updates 911 Cup and GT3 R Race Cars
The Porsche 911 family has been getting a mid-life makeover, and it is not just the road cars that have been treated. Two of the brand’s factory-built racers, the 911 Cup and the 911 GT3 R, now sport updates for the coming racing seasons.
The 911 Cup, a familiar sight in the F1-supporting Carrera Supercup and numerous national series, gains subtle styling changes in line with the road-going GT3 facelift. It’s naturally aspirated 4.0-litre flat-six now delivers 513 bhp, an increase of 10 bhp. Aerodynamic revisions improve airflow and downforce, while uprated brakes, a sturdier clutch and a simplified cockpit aim to make it even more competitive.
For those graduating from the Cup to bigger challenges, the updated 911 GT3 R has been prepared for global GT3 competition, including the World Endurance Championship and the 24 Hours of Le Mans. Like its smaller sibling, it gets aerodynamic enhancements, revised ABS, improved power steering and ceramic wheel bearings. Several sensors that were previously optional are now standard. It’s 4.2-litre flat-six produces up to 557 bhp, depending on series regulations.
Porsche will also offer upgrade kits for existing GT3 R models, allowing teams to bring older cars up to the latest specification. In motorsport, where margins are slim and reliability is paramount, that could be a strategic advantage.
With both cars sharpened and ready, the 911 racing lineage looks set to continue its long-standing habit of filling trophy cabinets.
Continue Reading
-
Healthcare Visits Increase Up to 15 Years Before MS Onset
TOPLINE:
Healthcare use was elevated much earlier than previously recognized among patients with multiple sclerosis (MS) in new research. Physician visits for “ill-defined symptoms and signs” increased from 15 years before MS symptom onset and mental health-related and psychiatry visits increased 14 years and 12 years before, respectively. However, nervous system-related and neurology visits increased significantly only 4 years and 8 years before the onset of MS symptoms.
METHODOLOGY:
- The cohort study included more than 2000 patients with MS (mean age at symptom onset, 38 years; 74% women) with a known date of MS symptom onset. Data were obtained from the British Columbia MS clinical database (1991-2018).
- Each patient with MS was matched by sex, birth year, socioeconomic status, and postal code at the year of MS onset with up to five individuals without MS randomly selected from the general population in British Columbia.
- Researchers compared annual rates of physician visits during the 25 years before MS onset between the cohorts.
- They also compared the difference in annual physician visit rates during the 15 years before MS onset on the basis of the International Classification of Diseases, Ninth Revision chapter and physician specialty.
TAKEAWAY:
- All-cause physician visit rate ratios (RRs) for patients with MS were consistently elevated from 14 years before MS onset (adjusted RR, 1.2; 95% CI, 1.1-1.3), peaking in the year before MS onset (adjusted RR, 1.3; 95% CI, 1.2-1.4).
- Mental health-related and psychiatry visits increased significantly from 14 years and 12 years before MS onset (RRs; 1.8 and 2.6, respectively), with both remaining elevated in most subsequent years.
- In contrast, neurology visits were significantly elevated for up to 8 years before MS onset (RR, 1.6) and nervous system conditions were elevated from only 4 years before (RR, 1.4), both peaking in the year before onset.
- Healthcare visits for ill-defined symptoms and signs consistently exceeded 1.15 from 15 years before MS onset, peaking in the year before (RR, 1.4).
IN PRACTICE:
“MS can be difficult to recognize as many of the earliest signs — like fatigue, headache, pain, and mental health concerns — can be quite general and easily mistaken for other conditions,” study investigator Helen Tremlett, The University of British Columbia and Djavad Mowafaghian Centre for Brain Health, Vancouver, British Columbia, Canada, said in a press release.
“Our findings dramatically shift the timeline for when these early warning signs are thought to begin. By identifying these earlier red flags, we may eventually be able to intervene sooner — whether that’s through monitoring, support, or preventive strategies,” Tremlett added.
SOURCE:
This study was led by Marta Ruiz-Algueró, MD, PhD, The University of British Columbia and Djavad Mowafaghian Centre for Brain Health. It was published online on August 1 in JAMA Network Open.
LIMITATIONS:
This study lacked detailed clinical information and only considered issues that prompted individuals to seek medical care. Potential miscoding or misclassification may have occurred. Additionally, a potential recall bias and challenges with medical history taking may have influenced the findings.
DISCLOSURES:
This study was funded in part by the National Multiple Sclerosis Society and MS Canada. Several investigators reported having financial ties with various sources either during the conduct of the study or outside the submitted work. Full details are provided in the original article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Continue Reading
-
Nvidia, AMD agree to pay U.S. government 15% of A.I. chip sales to China – The Washington Post
- Nvidia, AMD agree to pay U.S. government 15% of A.I. chip sales to China The Washington Post
- Chip giants Nvidia and AMD to pay 15% of China revenue to US BBC
- US licenses Nvidia to export chips to China after CEO meets Trump Financial Times
- US government turmoil stalls thousands of export approvals, sources say Reuters
- US government to take cut of Nvidia and AMD AI chip sales to China The Indian Express
Continue Reading
-
Antofagasta H1 2025 Earnings: Copper Tariffs Create New Dynamics
When is Antofagasta reporting?
Antofagasta is scheduled to report half-year (H1) 2025 earnings on Thursday, 14 August.
The results are expected to demonstrate continued operational excellence despite the evolving trade environment. Deutsche Bank forecasts earnings before interest, taxes, depreciation, and amortization (EBITDA) of around $2.05 billion for H1 2025.
Company backdrop
The company delivered 315,000 tonnes of copper production in the first half, maintaining guidance for sequential output increases through the remaining quarters. This consistent production performance reflects the quality of Antofagasta’s Chilean mining operations.
Management has kept full-year production guidance unchanged, providing confidence in the company’s ability to meet targets despite broader industry challenges including trade tensions. The operational resilience has been a key factor behind the stock’s outperformance this year.
What to watch for
US copper tariffs reshape market dynamics
The landscape for copper producers shifted dramatically on 1 August, when the United States (US) government implemented a 50% tariff on semi-finished copper products. This policy change creates both challenges and opportunities for major producers like Antofagasta as they navigate the new trade environment.
The tariff specifically targets semi-finished copper products while excluding raw copper materials such as ores, concentrates, and cathodes. This distinction is crucial for Antofagasta, as much of its export business focuses on these raw materials that remain unaffected by the new duties.
However, the company has expressed concerns that the tariffs will raise costs for US buyers and potentially disrupt established supply chains. The policy aims to boost America’s domestic copper processing industry, which has seen significant decline in recent decades.
Initial market reactions saw copper prices spike before settling as traders digested the scope of the tariff exclusions.
Antofagasta positioned to navigate tariff challenges
Despite the tariff implementation, Antofagasta’s business model provides some insulation from the most severe impacts. The company’s focus on raw copper exports means its core products avoid the 50% duties imposed on processed materials.
Antofagasta’s chief executive officer (CEO) has acknowledged the challenge posed by increased costs for US buyers, while also highlighting potential long-term opportunities. The company’s stalled Minnesota copper project could benefit from a strengthened US mining and processing industry over time.
The tariff environment introduces additional complexity to pricing negotiations and supply chain management. US buyers may seek to renegotiate contract terms or explore alternative suppliers, creating potential volume pressures for Chilean producers.
However, global copper supply remains tight due to supply-demand imbalances and strong demand driven by electrification trends. This fundamental backdrop should support pricing power for efficient producers like Antofagasta, even amid trade policy uncertainty.
Investment cycle pressures persist amid tariff uncertainty
The company’s substantial $2 billion investment in water infrastructure at Los Pelambres mine continues to reshape its financial profile, with negative free cash flow expected throughout 2025. This investment cycle pressure now coincides with trade policy uncertainty.
Net debt is projected to reach around $2.2 billion at the half-year point, reflecting the funding requirements of ongoing capital programmes. The tariff environment could potentially impact cash flow generation if US demand patterns shift significantly.
However, the long-term nature of infrastructure investments means these projects should deliver benefits regardless of short-term trade policy changes. The Los Pelambres water project positions the company for sustained production over many years.
Deutsche Bank analysts expect a dividend of approximately $0.14 per share, based on the company’s established 35% payout ratio. This demonstrates management’s commitment to shareholder returns despite current investment pressures and trade uncertainties.
Copper market fundamentals remain supportive
Despite tariff-related volatility, underlying copper market dynamics continue to support producer margins. Major analysts forecast continued price strength through 2025, with some predicting prices above $10,000 per tonne by year-end.
Global supply constraints persist due to limited new mine development and declining ore grades at existing operations. Meanwhile, demand from electrification trends, renewable energy infrastructure, and electric vehicle (EV) production continues growing.
The US tariff policy, while creating short-term disruption, reflects recognition of copper’s strategic importance for energy transition goals. This policy focus should support long-term demand even as trade flows potentially shift between regions.
Antofagasta technical analysis
While the shares have gained steadily from the lows of April, recording higher highs and higher lows, they have now reached the £20 area which has marked the highs since last September. This has created an area of strong resistance, and could see the shares struggle here once again.
A close above £21 would mark a bullish development, bolstering the current uptrend. Short-term weakness may find support at £18, or at the June low at £16.75.
Antofagasta daily chart
Continue Reading
-
Exciting Whatsapp Update: Fun Music And Collage
WhatsApp has recently unveiled some truly amazing features that are set to enhance user experience significantly. Among these updates, one of the most exciting is the introduction of a fun-filled music feature, accompanied by a brand new collage layout. This innovative addition aims to bring a fresh and engaging way for users to share and enjoy music within the app.
With this new music feature, users can easily explore and share their favorite tunes directly through the chat interface. Whether you want to send a catchy song to a friend or create a musical atmosphere during a group chat, whatsapp has made it seamless and enjoyable. The ability to integrate music into conversations adds a vibrant layer of interaction, transforming standard messaging into a more dynamic experience.
The collage layout is another standout aspect of this update. It allows users to combine multiple images and create visually appealing collages that can accompany their musical messages. This feature not only enhances the aesthetic appeal of shared content but also allows for more creativity in how users express themselves. By combining music with personalized visuals, users can craft unique messages that resonate on a deeper level.
To understand how these features work, users can easily navigate through a user-friendly interface that guides them in selecting songs from their favorite platforms, such as Spotify or apple Music. The collage tool provides a variety of templates and customization options, enabling users to create stunning visual representations of their musical choices.
In conclusion, WhatsApp’s new features promise to make communication even more enjoyable and expressive. By integrating music and innovative collage layouts into chats, users can look forward to a fun-filled experience that enriches their interactions. So, dive in and discover the exciting possibilities that await you with these latest updates!
Disclaimer: This content has been sourced and edited from Indiaherald. While we have made adjustments for clarity and presentation, the unique content material belongs to its respective authors and internet site. We do not claim possession of the content material.
Continue Reading
-
Kathie Lee Gifford remembers late hubby on anniversary of death
Kathie Lee Gifford honors hubby Frank on his 10th death anniversary Kathie Lee Gifford is remembering her husband Frank Gifford on his 10th death anniversary.
Taking to her Instagram handle, the 71-year-old former talk show host paid an emotional tribute to Frank and her friend, Hoda Kotb, as well.
“Today is a day for rejoicing!” she began the lengthy note. “First of all, I rejoice for my precious friend, Hoda Mama, on the occasion of her Birthday. “
“She is one of the most spectacular people I have ever known and I adore her and I want all her dreams to come true,” she added.
Revealing why she chooses to “rejoice” on the anniversary of Frank’s death, the former Today co-host said, “My precious husband, Frank, went home to Jesus 10 years ago today, and he has been at peace and filled with joy and glory since that very day.”
“I find comfort in that. So, I’m rejoicing in the Lord and how He cares for His loved ones, for His children,” she continued.
Concluding the post, Kathie penned, “Bless all of you today. And I hope you can find the same kind of Shalom in your lives.”
Alongside the note, Kathie shared an adorable photo of herself hugging Hoda in NYC’s Rockefeller Center, where the Today show is filmed.
For those unversed, Kathie and Hoda co-hosted the fourth hour of the NBC broadcast from 2008 to 2019.
Kathie’s husband Frank breathed his last in 2015 at the age of 84.
Continue Reading
-
Jennifer Lopez keeps her cool during onstage mishap
Jennifer Lopez keeps calm during onstage crisis Jennifer Lopez recently faced onstage cricket crisis during her latest performance at the Up All Night: Live in 2025 tour in Almaty, Kazakhstan, on Aug 10.
The iconic singer was in the middle of her performance when an unexpected guest joined her on stage, a large cricket that crawled up her dress and toward her neck.
Instead of panicking, Lopez smoothly grabbed the insect and tossed it aside, all without missing a note.
She quipped, “It was tickling me,” with a flashing smile before seamlessly continuing her set.
Fans quickly shared video footage of the moment, with Lopez’s official fan account joking, “Plot twist: @JLo just started rehearsals for Kiss of the Cricket Woman … on stage … in real time. ????????????.”
Supporters and fans praised her calmness, with one commenting, “She is just the best! ???? really fun moment but so professional at the same time! ????”
Another fan commented, “The cricket walking on her neck and she’s just chill, finishing the song like nothing’s going on. Then at the end, she takes the bug off with total class! If it were me, I’d be screaming already! ????????????”
Continue Reading